Access Statistics for Mark Sculpher

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis 0 0 0 38 0 0 2 309
Antenatal testing for HIV Infection: Developing a Model for Economic Evaluation 0 0 0 167 0 0 2 705
Appropriate Perspectives for Health Care Decisions 1 2 4 673 2 5 13 2,035
Building Uncertainty into Cost-Effectiveness Rankings: Portfolio Risk-Return Trade-Offs and Implications for Decision Rules 0 0 0 11 0 0 2 37
Comparing smoking cessation to screening and brief intervention for alcohol in distributional cost effectiveness analysis to explore the sensitivity of results to socioeconomic inequalities characterised in model inputs 0 0 1 2 1 1 4 19
Country-level cost-effectiveness thresholds: initial estimates and the need for further research 0 0 0 31 0 2 5 146
Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions 0 0 0 28 0 0 8 152
Defining and characterising structural uncertainty in decision analytic models 0 0 0 187 1 3 11 895
Economic Evaluation in Health Care Research and Development: Undertake it Early and Often 0 0 0 503 0 0 0 1,195
Economic analysis for health benefits package design 0 0 2 15 2 3 11 52
Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling 0 0 0 89 0 0 2 368
Income Effects of Reduced Health and Health Effects of Reduced Income: Implications for Health State Valuation 0 0 1 10 0 0 1 33
MRC-NICE scoping project: identifying the national institute for health and clinical excellence’s methodological research priorities and an initial set of priorities 0 0 0 22 0 0 2 146
Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions 1 3 3 370 2 5 10 1,065
Methods for the estimation of the NICE cost effectiveness threshold 0 4 12 188 2 8 27 761
Recognizing Preference Diversity: The Use of Preference Sub-Groups in Cost-Effectiveness Analysis 0 0 0 8 0 0 2 55
Scoping review on social care economic evaluation methods 1 1 2 69 1 5 16 267
Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision-makers 0 1 1 8 0 1 4 43
Supporting the development of an essential health package: principles and initial assessment for Malawi 0 0 2 67 2 6 16 305
The value of implementation and the value of information: combined and uneven development 0 0 0 34 1 2 7 180
Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? 1 1 3 160 1 2 12 490
Using electronic health records to predict costs and outcomes in stable coronary artery disease 0 0 1 3 0 0 2 11
Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS 1 3 6 707 1 4 12 2,217
Total Working Papers 5 15 38 3,390 16 47 171 11,486
1 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD 0 0 0 29 0 0 1 283
A Framework for Using Cost-effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence 0 0 0 0 0 1 1 1
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required 0 0 0 0 0 1 2 2
Acknowledging Patient Heterogeneity in Economic Evaluation 0 0 0 6 0 0 1 26
Adherence to the iDSI reference case among published cost-per-DALY averted studies 0 0 0 0 0 0 0 2
After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator? 0 0 0 5 0 0 2 31
An Iterative Bayesian Approach to Health Technology Assessment: Application to a Policy of Preoperative Optimization for Patients Undergoing Major Elective Surgery 0 0 1 1 0 0 1 3
An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? 0 0 0 6 0 0 0 48
Assessing Generalisability in Model-Based Economic Evaluation Studies 0 0 0 22 0 0 1 143
Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models 0 0 0 54 0 1 4 162
Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults: The Results of a Probabilistic Decision Model 0 0 0 1 0 0 2 7
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England 0 0 0 0 1 2 3 3
Authors’ Response to: “Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al.†by Sampson, Firth, and Towse 0 0 0 1 0 0 0 3
CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? 0 0 0 7 0 0 2 40
Catalogue of EQ-5D Scores for the United Kingdom 1 2 17 41 2 5 36 86
Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs 0 0 0 0 0 0 1 6
Cost-Effectiveness Analysis Using Data from Multinational Trials: The Use of Bivariate Hierarchical Modeling 0 0 0 0 0 0 0 1
Cost-Effectiveness Analysis of Acupuncture, Counselling and Usual Care in Treating Patients with Depression: The Results of the ACUDep Trial 0 0 0 0 0 2 4 12
Cost-Effectiveness Analysis of Treatments for Chronic Disease: Using R to Incorporate Time Dependency of Treatment Response 0 0 1 4 2 2 5 17
Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee 0 0 0 0 0 0 0 3
Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy 0 0 0 11 0 0 0 199
Dangerous omissions: the consequences of ignoring decision uncertainty 0 1 1 7 0 1 2 33
Developing the EQ-5D-5L Value Set for Uganda Using the ‘Lite’ Protocol 0 0 0 0 0 0 1 5
Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion 0 0 0 88 0 0 2 302
Distributional cost effectiveness analysis of West Yorkshire low emission zone policies 0 0 0 2 1 1 1 14
Effect of Treatment Interruption and Intensification of Antiretroviral Therapy on Health-Related Quality of Life in Patients with Advanced HIV 0 0 0 0 0 0 2 4
Efficiency, Equity, and Budgetary Policies 0 0 0 0 0 0 0 6
Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment 0 0 0 1 0 0 3 7
Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility 0 1 2 94 0 2 10 325
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates 0 0 0 0 0 0 0 0
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems 0 0 0 1 0 0 2 8
Estimating utility data from clinical indicators for patients with stable angina 0 0 0 4 0 0 1 25
Evidence synthesis, parameter correlation and probabilistic sensitivity analysis 0 0 0 69 0 0 0 267
Future Directions for Cost-effectiveness Analyses in Health and Medicine 0 0 1 1 1 1 5 16
Golimumab for the Treatment of Psoriatic Arthritis 0 0 0 7 0 0 0 161
Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts 0 0 0 2 0 0 2 11
Health-related quality of life implications of plantar ulcers resulting from neuropathic damage caused by leprosy: An analysis from the trial of autologous blood products (TABLE trial) in Nepal 0 0 0 0 0 0 0 0
How to Invest in Getting Cost-effective Technologies into Practice? A Framework for Value of Implementation Analysis Applied to Novel Oral Anticoagulants 0 0 0 0 0 0 0 1
How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework 0 0 0 5 0 0 2 22
Identifying Research Priorities: The Value of Information Associated with Repeat Screening for Age-Related Macular Degeneration 0 0 0 1 0 0 0 2
Income Effects of Reduced Health and Health Effects of Reduced Income 0 0 0 0 0 0 0 0
Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies 0 0 0 1 0 0 0 20
Methods Development for Health Technology Assessment 0 0 0 0 0 0 0 0
Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations 0 0 4 84 0 1 8 282
Model Parameter Estimation and Uncertainty Analysis 0 0 0 0 0 0 2 9
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra 0 0 0 159 0 1 5 609
Program Evaluation of Population- and System-Level Policies: Evidence for Decision Making 0 0 0 0 0 0 1 6
Real Economics Needs to Reflect Real Decisions 0 0 0 23 0 0 0 86
Recognising diversity in public preferences: the use of preference sub‐groups in cost‐effectiveness analysis. Authors' reply 0 0 0 4 0 0 1 46
Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis 0 0 0 13 0 0 3 110
Recombinant Erythropoietin for Chemotherapy-Related Anaemia 0 0 0 23 0 0 1 220
Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care 0 0 0 0 0 0 3 10
Representing uncertainty: the role of cost‐effectiveness acceptability curves 0 0 0 175 1 1 8 510
Sensitivity analysis in economic evaluation: A review of published studies 0 0 2 14 0 1 5 88
Shared treatment decision making in a collectively funded health care system: possible conflicts and some potential solutions 0 0 0 4 0 0 0 23
Should the Lambda (λ) Remain Silent? 0 0 0 5 0 0 1 29
Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods 0 0 0 27 0 0 3 108
Social value and individual choice: The value of a choice‐based decision‐making process in a collectively funded health system 0 0 0 0 0 0 0 8
Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers 0 0 0 7 1 2 7 58
The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis 0 0 1 1 0 0 2 8
The Value of Implementation and the Value of Information: Combined and Uneven Development 0 0 0 0 0 0 1 2
The cost‐effectiveness of preference‐based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia 0 0 0 0 0 0 0 47
Unfinished Symphony: A Tribute to the Life and Career of Bernie O’Brien (1959–2004) 0 0 0 0 0 0 0 0
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How? 0 0 0 0 0 0 0 0
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment 0 0 1 1 0 0 2 2
What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer 0 0 0 3 0 0 1 32
Whither trial‐based economic evaluation for health care decision making? 0 0 0 64 0 1 2 267
Total Journal Articles 1 4 31 1,078 9 26 155 4,867


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Decision Modelling for Health Economic Evaluation 0 0 0 0 5 19 124 3,991
Productivity Costs: Principles and Practice in Economic Evaluation 1 1 5 100 2 4 24 408
Total Books 1 1 5 100 7 23 148 4,399


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Cost-Effectiveness Thresholds: Guiding Health Care Spending for Population Health Improvement 0 0 1 20 0 1 4 45
Decision-making with Uncertainty: The Value of Information 0 0 0 36 0 0 6 124
Decision-making with Uncertainty: The Value of Information 1 1 1 14 1 1 3 41
Supporting the Development of Health Benefits Packages (HBPs): Principles and Initial Assessment for Malawi 0 0 1 2 0 0 2 8
Total Chapters 1 1 3 72 1 2 15 218


Statistics updated 2025-07-04